Screening Peptides Binding Specifically to Colorectal Cancer Cells from a Phage Random Peptide Library |
Wang, Jun-Jiang
(Department of Gastroenterology Surgery, Guangdong General Hospital)
Liu, Ying (Department of Obstetrics and Gynecology, Guangdong General Hospital) Zheng, Yang (Department of Gastroenterology Surgery, First Affiliated Hospital of Shan-tou University Medical College) Liao, Kang-Xiong (Department of General Surgery, the Jieyang People's Hospital) Lin, Feng (Department of Gastroenterology Surgery, Guangdong General Hospital) Wu, Cheng-Tang (Department of General Surgery, Nanfang Hospital, Southern Medical University) Cai, Guan-Fu (Department of Gastroenterology Surgery, Guangdong General Hospital) Yao, Xue-Qing (Department of Gastroenterology Surgery, Guangdong General Hospital) |
1 | Shukla GS, Krag DN (2005). Phage display selection for cellspecific ligands, development of a screening procedure suitable for small tumor specimens. J Drug Target, 13, 7-18. DOI |
2 | Smith P (1985). Filamentous fusion phage, novel expression vectors that display cloned antigens on the virion surface. Science, 228, 1315- 7. DOI |
3 | Xu R, Zhou B, Fung PC, et al (2006). Recent advances in the treatment of colorectal cancer. Histol Histopathol, 21, 867-72. |
4 | Zhang J, Spring H, Schwab M (2001). Neuroblastoma tumor cell-binding peptides identified through random peptide phage display. Cancer Lett, 171, 153-64. DOI |
5 | Zhang L, Yin G, Yan D, et al (2011). In vitro screening of ovarian tumor specific peptides from a phage display peptide library. Biotechnol Lett, 33, 1729-35. DOI |
6 | Landon LA, Zou J, Deutscher SL (2004). Is phage display technology on target for developing peptide-based cancer drugs? Curr Drug Discov Technol, 1, 113-32. DOI |
7 | Lee TY, Wu HC, Tseng YL, et al (2004). A novel peptide specifically binding to nasopharyngeal carcinoma for targeted drug delivery. Cancer Res, 64, 8002-8. DOI |
8 | Lo A, Lin CT, Wu HC (2008). Hepatocellular carcinoma cellspecific peptide ligand for targeted drug delivery. Mol Cancer Ther, 7, 579-89. DOI |
9 | Nicklin SA, White SJ, Watkins SJ, et al (2000). Selective targeting of gene transfer to vascular endothelial cells by use of peptides isolated by phage display. Circulation, 102, 231-7. DOI |
10 | Luck K, Trave G (2011). Phage display can select overhydrophobic sequences that may impair prediction of natural domain-peptide interactions. Bioinformatics, 27, 899-902. DOI |
11 | Oh P, Li Y, Yu J, et al (2004). Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissuespecific therapy. Nature, 429, 629-35. DOI |
12 | Oyama T, Sykes KF, Samli KN, et al (2003). Isolation of lung tunlor specific pepfides from a random peptide library, generation of diagnostic and cell-targeting reagents. Cancer Lett, 202, 219-30. DOI |
13 | Rusu D, Loret S, Peulen O, et al (2005). Immunochemical, biomolecular and biochemical characterization of bovine epithelial intestinal primocultures. BMC Cell Biology, 6, 42. DOI |
14 | Samoylova TI, Morrison NE, Globa LP, et al (2006). Peptide Phage Display, Opportunities for Development of Personalized Anti-Cancer Strategies. Anticancer Agents Med Chem, 6, 9-17. DOI |
15 | Shadidi M, Sioud M (2003). Selective targeting of cancer cells using synthetic peptides. Drug Resist Updat, 6, 363-71. DOI |
16 | Shanmugam A, Suriano R, Chaudhuri D, et al (2011). Identification of PSA peptide mimotopes using phage display peptide library. Peptides, 32, 1097- 102. DOI |
17 | Karjalainen K, Jaalouk DE, Bueso-Ramos CE, et al (2011). Targeting neuropilin-1 in human leukemia and lymphoma. Blood, 117, 920-7. DOI |
18 | Cao Q, Liu S, Niu G, et al (2011). Phage display peptide probes for imaging early response to bevacizumab treatment. Amino Acids, 41, 1103-12. DOI |
19 | De Bolle X, Laurent T, Tibor A, et al (1999). Antigenic properties of peptidic mimics for epitopes of the lipopolysaccharide from Brucella. J Mol Biol, 294, 181-91. DOI |
20 | Grossmann J, Walther K, Artinger M, et al (2003). Progress on isolation and short-term ex-vivo culture of highly purified non-apoptotic human intestinal epithelial cells (IEC). Eur J Cell Biol, 5, 262-70. |
21 | Kehoe JW, Kay BK (2005). Filamentous phage display in the new millennium. Chem Rev, 105, 4056-72. DOI |
22 | Krag DN, Shukla GS, Shen GP, et al (2006). Selection of Tumorbinding Ligands in Cancer Patients with Phage Display Libraries. Cancer Res, 66, 7724- 33. DOI |